HealthTech Arkansas, VC agency companion on biotherapeutics accelerator
HealthTech Arkansas and SymBiosis Capital Administration introduced Wednesday (Oct. 19) that they might collaborate on a biotherapeutics-focused accelerator program known as BioAR Trial.
In keeping with a information launch, the startup program will assist biotherapeutics firms within the late pre-clinical levels of improvement convey groundbreaking therapies to market quicker whereas rising Arkansans’ entry to cutting-edge scientific care and revolutionary medicines.
Based in 2021, SymBiosis is a enterprise capital funding agency in Bentonville with a number of of its management group and long-term buyers dwelling in Northwest Arkansas, together with managing companion Chidozie Ugwumba. The agency invests in groundbreaking medicines throughout illness areas, financing levels and geography, with a give attention to packages in or about to enter human trials. It manages a portfolio of greater than 30 investments and has vital, long-term capital commitments to fund future investments.
“Our purpose at SymBiosis is to make investments that assist convey revolutionary therapeutics to market to enhance and save lives,” Ugwumba stated within the launch. “We’re happy to companion with HealthTech Arkansas to make our shared imaginative and prescient of BioAR Trial a actuality. We count on this to be the primary in a sequence of initiatives that assist rework Arkansas right into a nationwide chief in healthcare. We’re excited for what we anticipate will probably be a robust response to this distinctive alternative and to start working with the collaborating firms to advance their biotherapeutics.”
The applying for BioAR Trial is open by means of Jan. 15, 2023, at bioarkansas.co. The BioAR Trial choice committee contains representatives from companion well being techniques and scientific trials websites who will evaluate functions and establish ten finalists. The choice committee will select the 5 collaborating firms in March 2023. The primary cohort of 5 firms will start in April 2023.
BioAR Trial’s companion hospitals and well being techniques are:
- Arkansas Kids’s Analysis Institute
- Arkansas Coronary heart Hospital
- Baptist Well being
- CHI St. Vincent
- Highlands Oncology Group
- Bernards Healthcare
- College of Arkansas for Medical Sciences
HealthTech Arkansas is in its fifth yr of administering accelerator packages targeted completely on supplier engagement with early-stage firms. It really works with each Arkansas-based and out-of-state firms.
“Partnering with SymBiosis to ascertain BioAR Trial is a crucial subsequent step in direction of reaching our purpose of driving innovation for Arkansas healthcare suppliers by means of our accelerators and inner innovation programming,” stated HealthTech Arkansas director Jeff Stinson. “We’re happy to couple our healthcare accelerator’s potential to supply high-quality scientific trial websites for promising early-stage firms with SymBiosis’ deep experience in serving to biotherapeutic firms to meet their very important missions.”
